Mexico issues regulations to approve biologic drugs

by Gustavo Alcocer & Enrique Lara Personal data protection has always been recognised as a fundamental human right by most jurisdictions all over the world. In Mexico it was not until a few years ago, when amendments were made to our legal system to regulate personal data protection, following international principles of transparency, legitimate use and proportionality […]
por Agustín Azcatl Under the amendment made to the Articles 168 and 170 of the Health Supplies Regulation, about the omission of the requirement for a manufacturing plant, last May 5, 2011, the Mexican Government granted the first Marketing Authorization (drug licensing) through the Health Ministry (The Federal Commission for Protection against Sanitary Risk COFEPRIS) to […]
POR RICARDO CADENA MANAGING INTELLECTUAL PROPERTY, DECEMBER 2010 / JANUARY 2011 Enforcing security interests is not always as simple as we may want it to be, especially when it comes to chasing debtors who retain title or possession of secured IP, or any movable asset colateral, where the debtor can assign or set that asset as […]
por Gustavo Alcocer & Carlos Woodworth 1 Relevant authorities and legislation 1.1 Who is/are the relevant merger authority(ies)? The Federal Competition Commission, which is an administrative agency independent from the Mexican Ministry of Economy, has technical and operational autonomy to issue its resolutions. The Commission is integrated to exercise merger authority by public officials, divisions and administrative […]